Cite
HARVARD Citation
Alinari, L. et al. (n.d.). De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. American journal of hematology. 91 (4), pp. 395-399. [Online].